Interventional Cardiology Experts from CRF Available for Comment at ACC.18

News Archive

New York, NY – March 6, 2018 – Leading interventional cardiology experts from the Cardiovascular Research Foundation (CRF) will be presenting at the American College of Cardiology’s 67th Annual Scientific Session taking place March 10-12, 2018 at the Orange County Convention Center in Orlando, FL. Below is a list of presentations as well as top experts available for comment on research being presented at this year’s meeting.

Presentations

615-08 Left Main Disease- NOBLE, EXCEL, Now What?

Hybrid Coronary Revascularization: Where Did It Go or Is It Here to Stay?

Gregg W. Stone, MD

Saturday, March 10, 2018, 12:25 PM - 12:35 PM; Room 204C

903-08 - Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Highlighted Original Research: Interventional Cardiology and the Year in Review

Ajay J. Kirtane, MD

Sunday, March 11, 2018, 8:38 AM - 8:48 AM; Room 204C

 

Experts Available for Comment

Gregg W. Stone, MD is Professor of Medicine at the Columbia University Medical Center, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital, and Co-Director of Medical Research and Education at the Cardiovascular Research Foundation. Dr. Stone has served as the national or international principal investigator for approximately 100 national and international multicenter randomized trials (many of which have led to new device approval or indications in the U.S.), has authored more than 2,000 manuscripts and abstracts published in peer-reviewed literature as well as numerous book chapters, and has delivered thousands of invited lectures around the world. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter mitral valve repair and replacement; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; new device angioplasty including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; left atrial appendage closure; contrast nephropathy; clinical trial design; and regulatory issues.

Juan F. Granada, MD, is the President and Chief Executive Officer of the Cardiovascular Research Foundation (CRF). A renowned leader in cardiology, he joined CRF in 2007 and served as Executive Director and Chief Innovation Officer at the CRF Skirball Center for Innovation, the preclinical division of CRF. He is also an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons. Dr. Granada is one of the world’s foremost investigators in the translational validation of novel cardiovascular therapies and has helped develop and successfully validate several endovascular imaging and device technologies.  

Ori Ben-Yehuda, MD, is Executive Director of the CRF Clinical Trials Center (CTC) and an experienced cardiologist and co-author of numerous scientific publications in top tier medical journals. He has been a clinical researcher for two decades and is the Deputy Editor of Structural Heart: The Journal of the Heart Team. He was formerly Deputy Editor of the Journal of the American College of Cardiology from 2002 through 2010.

Ajay J. Kirtane, MD, SM, is Associate Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center. He is also co-director of CRF’s Transcatheter Cardiovascular Therapeutics meeting. Dr. Kirtane is a practicing cardiologist with an interest in coronary and peripheral intervention. His research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in interventional cardiology. He has authored or co-authored more than 150 original manuscripts and over 50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in interventional cardiology. He has been principal investigator for several multicenter trials of interventional devices and serves on the steering committees of several large-scale clinical trials in interventional cardiovascular medicine.

To learn more about CRF’s research and educational programs at ACC.18, visit Booth #3035.